3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

16,183

15,502

受取手形及び売掛金

22,800

20,904

電子記録債権

4,196

4,152

商品及び製品

15,379

15,240

仕掛品

4,860

3,141

原材料及び貯蔵品

6,753

5,498

その他

1,260

955

貸倒引当金

19

43

流動資産合計

71,416

65,352

固定資産

 

 

有形固定資産

 

 

建物及び構築物

47,621

48,583

減価償却累計額

30,544

31,067

建物及び構築物(純額)

17,077

17,516

機械装置及び運搬具

75,559

66,142

減価償却累計額

67,927

57,204

機械装置及び運搬具(純額)

7,632

8,938

工具、器具及び備品

7,698

7,895

減価償却累計額

6,421

6,605

工具、器具及び備品(純額)

1,276

1,289

土地

13,493

13,259

建設仮勘定

5,040

2,163

有形固定資産合計

44,520

43,167

無形固定資産

 

 

のれん

777

666

その他

273

465

無形固定資産合計

1,050

1,132

投資その他の資産

 

 

投資有価証券

5,120

6,215

退職給付に係る資産

104

150

繰延税金資産

648

715

その他

489

515

貸倒引当金

31

31

投資その他の資産合計

6,332

7,565

固定資産合計

51,903

51,864

資産合計

123,319

117,216

 

 

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

支払手形及び買掛金

8,561

8,632

短期借入金

11,512

8,357

未払法人税等

767

1,275

賞与引当金

1,341

1,338

その他の引当金

124

117

その他

5,603

5,551

流動負債合計

27,910

25,272

固定負債

 

 

転換社債型新株予約権付社債

3,000

3,000

長期借入金

7,406

4,643

環境対策引当金

145

166

退職給付に係る負債

4,547

4,117

繰延税金負債

642

878

その他

280

215

固定負債合計

16,022

13,021

負債合計

43,933

38,293

純資産の部

 

 

株主資本

 

 

資本金

21,838

21,838

資本剰余金

16,774

14,300

利益剰余金

37,767

38,339

自己株式

1,701

1,706

株主資本合計

74,679

72,771

その他の包括利益累計額

 

 

その他有価証券評価差額金

2,223

3,026

繰延ヘッジ損益

6

14

為替換算調整勘定

1,151

1,255

退職給付に係る調整累計額

207

633

その他の包括利益累計額合計

3,576

4,901

新株予約権

35

35

非支配株主持分

1,095

1,214

純資産合計

79,386

78,923

負債純資産合計

123,319

117,216

 

E0078040780堺化学工業株式会社Sakai Chemical Industry Co.,Ltd通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse407802024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802024-03-31jppfs_cor:CapitalStockMember407802024-03-31jppfs_cor:CapitalSurplusMember407802024-03-31jppfs_cor:RetainedEarningsMember407802024-03-31jppfs_cor:TreasuryStockMember407802024-03-31jppfs_cor:ShareholdersEquityMember407802024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802024-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802024-03-31jppfs_cor:NonControllingInterestsMember407802024-04-012025-03-31jppfs_cor:RetainedEarningsMember407802024-04-012025-03-31jppfs_cor:CapitalStockMember407802024-04-012025-03-31jppfs_cor:CapitalSurplusMember407802024-04-012025-03-31jppfs_cor:TreasuryStockMember407802024-04-012025-03-31jppfs_cor:ShareholdersEquityMember407802024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802024-04-012025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-03-31jppfs_cor:CapitalStockMember407802024-04-012025-03-31jppfs_cor:NonControllingInterestsMember407802025-03-31jppfs_cor:CapitalSurplusMember407802025-03-31jppfs_cor:RetainedEarningsMember407802025-04-012026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:TreasuryStockMember407802025-04-012026-03-31jppfs_cor:ShareholdersEquityMember407802026-03-31jppfs_cor:ShareholdersEquityMember407802026-03-31jppfs_cor:CapitalStockMember407802026-03-31jppfs_cor:CapitalSurplusMember407802026-03-31jppfs_cor:RetainedEarningsMember407802026-03-31jppfs_cor:TreasuryStockMember407802026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802026-03-31jppfs_cor:NonControllingInterestsMember407802025-04-012026-03-31jppfs_cor:CapitalSurplusMember407802025-04-012026-03-31jppfs_cor:RetainedEarningsMember407802025-04-012026-03-31jppfs_cor:TreasuryStockMember407802025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802025-04-012026-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802025-04-012026-03-31jppfs_cor:NonControllingInterestsMember407802025-03-31jpcrp_cor:ReportableSegmentsMember407802025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember407802024-04-012025-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802026-03-31jpcrp_cor:ReconcilingItemsMember407802025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember407802025-03-31jpcrp_cor:ReconcilingItemsMember407802024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember407802026-03-31jpcrp_cor:OtherReportableSegmentsMember407802025-04-012026-03-31jpcrp_cor:OtherReportableSegmentsMember407802025-03-31jpcrp_cor:OtherReportableSegmentsMember407802024-04-012025-03-31jpcrp_cor:OtherReportableSegmentsMember407802026-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802026-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802026-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802026-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802025-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802025-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802025-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:ElectronicMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:CosmeticsMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:OrganicChemicalsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:HygienicProductsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:ContractProcessingReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:TitaniumDioxideAndZincProductsWithoutCosmeticsMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:PlasticAdditivesReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:CatalystsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:MedicalBusinessReportableSegmentMember407802026-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802025-04-012026-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802025-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802024-04-012025-03-31tse-acedjpfr-40780:InorganicMaterialsReportableSegmentMember407802026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember407802025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember407802025-03-31jppfs_cor:DeferredGainsOrLossesOnHedgesMember407802025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember407802025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember407802025-03-31jppfs_cor:NonControllingInterestsMember407802025-04-012026-03-31jppfs_cor:CapitalStockMember407802025-03-31jppfs_cor:ShareholdersEquityMember407802026-05-13407802026-03-31407802025-04-012026-03-31407802025-03-31407802024-04-012025-03-31407802024-03-31407802026-03-31jppfs_cor:SubscriptionRightsToSharesMember407802025-04-012026-03-31jppfs_cor:SubscriptionRightsToSharesMember407802025-03-31jppfs_cor:SubscriptionRightsToSharesMember407802024-04-012025-03-31jppfs_cor:SubscriptionRightsToSharesMember407802024-03-31jppfs_cor:SubscriptionRightsToSharesMember407802026-03-31jpcrp_cor:ReportableSegmentsMember407802026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMember407802025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember407802025-04-012026-03-31jpcrp_cor:UnallocatedAmountsAndEliminationMemberxbrli:pureiso4217:JPY